Castration anxiety.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Author(s): Appel JM;Appel JM
  • Source:
    Journal of bioethical inquiry [J Bioeth Inq] 2012 Mar; Vol. 9 (1), pp. 85-91. Date of Electronic Publication: 2011 Dec 22.
  • Publication Type:
    Journal Article
  • Language:
    English
  • Additional Information
    • Source:
      Publisher: Springer Country of Publication: Netherlands NLM ID: 101250741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-4353 (Electronic) Linking ISSN: 11767529 NLM ISO Abbreviation: J Bioeth Inq Subsets: MEDLINE
    • Publication Information:
      Publication: Dordrecht : Springer
      Original Publication: Dunedin, N.Z. : Bioethics Centre, University of Otago
    • Subject Terms:
      Orchiectomy*/adverse effects ; Orchiectomy*/ethics ; Orchiectomy*/legislation & jurisprudence ; Prisoners*; Medroxyprogesterone Acetate/*adverse effects ; Sex Offenses/*legislation & jurisprudence; Child ; Child Abuse, Sexual/legislation & jurisprudence ; Humans ; Louisiana ; Male ; Medroxyprogesterone Acetate/therapeutic use
    • Abstract:
      Chemical castration laws, such as one recently adopted in the U.S. State of Louisiana, raise challenging ethical concerns for physicians. Even if such interventions were to prove efficacious, which is far from certain, they would still raise troubling concerns regarding the degree of medical risk that may be imposed upon prisoners in the name of public safety as well as the appropriate role for physicians and other health care professionals in the administration of pharmaceuticals to competent prisoners over the inmates' unequivocal objections. This paper argues that the concerns raised by chemical castration are grave enough that, until they are adequately addressed by policymakers, physicians ought not to participate in the process.
    • References:
      Whittier Law Rev. 1997 Fall;19(1):169-213. (PMID: 12071202)
      Med Health R I. 2003 Nov;86(11):367-9. (PMID: 14692338)
      Arch Pediatr Adolesc Med. 2005 Feb;159(2):139-44. (PMID: 15699307)
      Univ Pittsbg Law Rev. 1997 Fall;59(1):157-92. (PMID: 14631990)
      Psychoneuroendocrinology. 2004 Sep;29(8):1071-81. (PMID: 15219659)
      Cochrane Database Syst Rev. 2000;(2):CD000251. (PMID: 10796706)
      Am J Psychiatry. 1981 May;138(5):601-7. (PMID: 6453535)
      Hastings Cent Rep. 2003 Sep-Oct;33(5):11-2. (PMID: 14696273)
      BMJ. 1994 Jan 22;308(6923):247-8. (PMID: 8111260)
    • Accession Number:
      C2QI4IOI2G (Medroxyprogesterone Acetate)
    • Publication Date:
      Date Created: 20121127 Date Completed: 20131224 Latest Revision: 20211021
    • Publication Date:
      20240829
    • Accession Number:
      10.1007/s11673-011-9341-z
    • Accession Number:
      23180204